Wolverine Trading, LLC Lannett CO Inc Put Options Transaction History

Wolverine Trading, LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 12, 2021	SELL	$2.91 - $4.83 $18,624 - $30,912	-6,400 Reduced 29.09%	15,600 $48,000
Q2 2021 Aug 06, 2021	BUY	$4.17 - $5.74 $20,850 - $28,700	5,000 Added 29.41%	22,000 $104,000
Q2 2020 Aug 13, 2020	SELL	$6.43 - $9.86 $91,306 - $140,012	-14,200 Reduced 45.51%	17,000 $121,000
Q1 2020 May 11, 2020	SELL	$6.36 - $10.05 $26,712 - $42,210	-4,200 Reduced 11.86%	31,200 $235,000
Q4 2019 Feb 12, 2020	BUY	$8.49 - $12.81 $300,546 - $453,474	35,400 New	35,400 $301,000
Q3 2019 Nov 14, 2019	SELL	$5.58 - $14.47 $159,588 - $413,842	-28,600 Closed	0 $0
Q2 2019 Aug 20, 2019	SELL	$5.22 - $9.08 $61,596 - $107,144	-11,800 Reduced 29.21%	28,600 $173,000
Q1 2019 May 15, 2019	BUY	$5.35 - $9.82 $28,354 - $52,046	5,300 Added 15.1%	40,400 $318,000
Q4 2018 Feb 14, 2019	SELL	$3.43 - $6.19 $162,239 - $292,787	-47,300 Reduced 57.4%	35,100 $179,000
Q3 2018 Nov 14, 2018	SELL	$4.75 - $14.5 $76,950 - $234,900	-16,200 Reduced 16.43%	82,400 $391,000
Q1 2018 May 15, 2018	BUY	$14.7 - $24.95 $482,160 - $818,360	32,800 Added 49.85%	98,600 $1.58 Million
Q4 2017 Feb 14, 2018	BUY	$19.9 - $29.25 $1.31 Million - $1.92 Million	65,800	65,800 $1.53 Million

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.